标题
NK cell therapy in relapsed refractory multiple myeloma
作者
关键词
-
出版物
CLINICAL IMMUNOLOGY
Volume -, Issue -, Pages 109168
出版商
Elsevier BV
发表日期
2022-10-30
DOI
10.1016/j.clim.2022.109168
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- NK cell-based cancer immunotherapy: from basic biology to clinical development
- (2021) Sizhe Liu et al. Journal of Hematology & Oncology
- Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma
- (2021) Tatiana Pazina et al. Cancers
- Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
- (2021) Nikhil C. Munshi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Syndecan-1 (CD138), Carcinomas and EMT
- (2021) John R. Couchman INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CAR T-cell therapy in multiple myeloma: more room for improvement
- (2021) Phaik Ju Teoh et al. Blood Cancer Journal
- Metabolic changes of Interleukin-12/15/18-stimulated human NK cells
- (2021) Iñigo Terrén et al. Scientific Reports
- Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future
- (2021) Margaret G. Lamb et al. Stem Cell Research & Therapy
- NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma
- (2021) Alejandra Leivas et al. Blood Cancer Journal
- CAR-NK Cells from Engineered Pluripotent Stem Cells: Off-the-shelf Therapeutics for all Patients
- (2021) Shi-Jiang Lu et al. Stem Cells Translational Medicine
- CAR T and CAR NK cells in multiple myeloma: Expanding the targets
- (2020) Urvi A. Shah et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Selinexor for the treatment of multiple myeloma
- (2020) Klaus Podar et al. EXPERT OPINION ON PHARMACOTHERAPY
- NK cells for cancer immunotherapy
- (2020) Noriko Shimasaki et al. NATURE REVIEWS DRUG DISCOVERY
- Multiple Myeloma: Available Therapies and Causes of Drug Resistance
- (2020) Vanessa Pinto et al. Cancers
- Immunotherapy of multiple myeloma
- (2020) Simone A. Minnie et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity
- (2020) Huang Zhu et al. Cell Stem Cell
- The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
- (2020) Tobias Bald et al. NATURE IMMUNOLOGY
- Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
- (2020) Keerthana Shankar et al. Stem Cell Research & Therapy
- CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions
- (2020) Luis Gerardo Rodríguez-Lobato et al. Frontiers in Oncology
- Pluripotent Stem Cell-Based Cell Therapy—Promise and Challenges
- (2020) Shinya Yamanaka Cell Stem Cell
- Multiple myeloma current treatment algorithms
- (2020) S. Vincent Rajkumar et al. Blood Cancer Journal
- Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical Trials
- (2020) Xinrong Xiang et al. Frontiers in Pharmacology
- Expanded NK cells from umbilical cord blood and adult peripheral blood combined with daratumumab are effective against tumor cells from multiple myeloma patients
- (2020) Chantal Reina-Ortiz et al. OncoImmunology
- Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma
- (2020) Astrid Tschan-Plessl et al. CYTOTHERAPY
- Evaluating the role of Tregs in the progression of multiple myeloma
- (2019) Deepesh Lad et al. LEUKEMIA & LYMPHOMA
- The Mechanism Of Action Of The Anti-CD38 Monoclonal Antibody Isatuximab In Multiple Myelmoa
- (2019) Laura Moreno et al. CLINICAL CANCER RESEARCH
- B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma
- (2019) Adam D. Cohen et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
- (2019) Noopur Raje et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma
- (2019) Jie Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of Automated Separation, Expansion, and Quality Control Protocols for Clinical-Scale Manufacturing of Primary Human NK Cells and Alpharetroviral Chimeric Antigen Receptor Engineering
- (2019) Olaf Oberschmidt et al. Human Gene Therapy Methods
- Multiple myeloma: Every year a new standard?
- (2019) S. Vincent Rajkumar HEMATOLOGICAL ONCOLOGY
- CD137 (4-1BB) Engagement Fine-Tunes Synergistic IL-15– and IL-21–Driven NK Cell Proliferation
- (2019) Laurent Vidard et al. JOURNAL OF IMMUNOLOGY
- Adoptive cell therapy using engineered natural killer cells
- (2019) Katayoun Rezvani BONE MARROW TRANSPLANTATION
- Pluripotent stem cell–derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity
- (2019) Huang Zhu et al. BLOOD
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- Immunopathogenesis and immunotherapy of multiple myeloma
- (2018) Hideto Tamura INTERNATIONAL JOURNAL OF HEMATOLOGY
- T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma
- (2018) Jennifer N. Brudno et al. JOURNAL OF CLINICAL ONCOLOGY
- Natural killer cell immunotherapy against multiple myeloma: Progress and possibilities
- (2018) Pan Liu et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natural Killer Cells: Development, Maturation, and Clinical Utilization
- (2018) Alex M. Abel et al. Frontiers in Immunology
- A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
- (2018) Wan-Hong Zhao et al. Journal of Hematology & Oncology
- Key Role of the CD56lowCD16low Natural Killer Cell Subset in the Recognition and Killing of Multiple Myeloma Cells
- (2018) Elisabetta Vulpis et al. Cancers
- Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
- (2017) E Liu et al. LEUKEMIA
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- (2017) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase I trial of NK-92 cells for refractory hematological malignancies relapsing after autologous hematopoietic cell transplantation shows safety and evidence of efficacy
- (2017) Brent A. Williams et al. Oncotarget
- Role of Distinct Natural Killer Cell Subsets in Anticancer Response
- (2017) Helena Stabile et al. Frontiers in Immunology
- Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation
- (2016) Veronika Bachanova et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Myeloid-derived suppressor cells: The green light for myeloma immune escape
- (2016) Ehsan Malek et al. BLOOD REVIEWS
- Selection and expansion of natural killer cells for NK cell-based immunotherapy
- (2016) Petra S. A. Becker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Preparation of Cytokine-activated NK Cells for Use in Adoptive Cell Therapy in Cancer Patients
- (2016) Monique M. van Ostaijen-ten Dam et al. JOURNAL OF IMMUNOTHERAPY
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- Multiple myeloma epidemiology and survival: A unique malignancy
- (2016) Dickran Kazandjian SEMINARS IN ONCOLOGY
- Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection
- (2016) Rohtesh S. Mehta et al. Virulence
- NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?
- (2016) Claudia Cantoni et al. Journal of Immunology Research
- Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma
- (2016) Alejandra Leivas et al. OncoImmunology
- Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds
- (2015) K. Lagrue et al. BLOOD
- Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A
- (2015) Subhashis Sarkar et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- NK-92: an ‘off-the-shelf therapeutic’ for adoptive natural killer cell-based cancer immunotherapy
- (2015) Garnet Suck et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Natural Killer Cell Adoptive Transfer Therapy
- (2015) Zachary B. Davis et al. CANCER JOURNAL
- Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment
- (2015) A. Ponzetta et al. CANCER RESEARCH
- IL-12/15/18-preactivated NK cells suppress GvHD in a mouse model of mismatched hematopoietic cell transplantation
- (2015) Christian M. Hüber et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
- (2015) Susann Szmania et al. JOURNAL OF IMMUNOTHERAPY
- Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I
- (2015) Guang Yang et al. Oncotarget
- “Adherent” versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy
- (2015) Senthamil R. Selvan et al. Biomed Research International
- Preactivation with IL-12, IL-15, and IL-18 Induces CD25 and a Functional High-Affinity IL-2 Receptor on Human Cytokine-Induced Memory-like Natural Killer Cells
- (2014) Jeffrey W. Leong et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL
- (2014) L. Oevermann et al. BLOOD
- Novel anti-B-cell maturation antigen antibody-drug conjugate (GSK2857916) selectively induces killing of multiple myeloma
- (2014) Y.-T. Tai et al. BLOOD
- Glucocorticoids regulate natural killer cell function epigenetically
- (2014) Justin L. Eddy et al. CELLULAR IMMUNOLOGY
- TGF- Utilizes SMAD3 to Inhibit CD16-Mediated IFN- Production and Antibody-Dependent Cellular Cytotoxicity in Human NK Cells
- (2014) R. Trotta et al. JOURNAL OF IMMUNOLOGY
- mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function
- (2014) Raymond P. Donnelly et al. JOURNAL OF IMMUNOLOGY
- IL-2–dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells
- (2013) Georg Gasteiger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
- (2013) J Chu et al. LEUKEMIA
- Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state
- (2013) James Favaloro et al. LEUKEMIA & LYMPHOMA
- Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells
- (2013) Subhashis Sarkar et al. PLoS One
- Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
- (2013) Nina Shah et al. PLoS One
- Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
- (2013) David A. Knorr et al. Stem Cells Translational Medicine
- Bringing natural killer cells to the clinic: ex vivo manipulation
- (2013) R. W. Childs et al. Hematology-American Society of Hematology Education Program
- Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry
- (2012) R. J. Pessoa de Magalhaes et al. HAEMATOLOGICA
- Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model
- (2012) B. E. Swift et al. HAEMATOLOGICA
- Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma
- (2012) Giuseppina Bonanno et al. Journal of Translational Medicine
- Glucocorticoid dysregulation of natural killer cell function through epigenetic modification☆
- (2010) Karen Krukowski et al. BRAIN BEHAVIOR AND IMMUNITY
- Dysregulation in T helper 1/T helper 2 cytokine ratios in patients with multiple myeloma
- (2010) Alpana Sharma et al. LEUKEMIA & LYMPHOMA
- Pluripotent stem cell-derived natural killer cells for cancer therapy
- (2010) David A. Knorr et al. Translational Research
- Natural Killer Cells in Allogeneic Transplantation: Effect on Engraftment, Graft- versus-Tumor, and Graft-versus-Host Responses
- (2009) Saar Gill et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Interleukin-6 leads to interleukin-10 production in several human multiple myeloma cell lines. Does interleukin-10 enhance the proliferation of these cells?
- (2009) Eva Kovacs LEUKEMIA RESEARCH
- Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components
- (2008) E. Alici et al. BLOOD
- Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma
- (2008) R A Kyle et al. LEUKEMIA
- The dysfunction and abnormal signaling pathway of dendritic cells loaded by tumor antigen can be overcome by neutralizing VEGF in multiple myeloma
- (2008) Deok-Hwan Yang et al. LEUKEMIA RESEARCH
- Natural killer cell–directed therapies: moving from unexpected results to successful strategies
- (2008) Magali Terme et al. NATURE IMMUNOLOGY
- MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma
- (2008) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Biology of Interleukin-2
- (2007) Thomas R. Malek Annual Review of Immunology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started